Full-Time

Executive Director – Customer Engagement Lead

Type 1 Diabetes

Confirmed live in the last 24 hours

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$268k - $402k/yr

+ Bonus + Equity Awards

Senior, Expert

Company Does Not Provide H1B Sponsorship

Boston, MA, USA

Category
Strategic Account Management
Sales & Account Management
Required Skills
Marketing
Data Analysis
Requirements
  • Bachelor's degree
  • 15+ years of experience in healthcare/biopharmaceuticals with a mix of field, marketing, account management or an equivalent combination of experience and education
  • 5+ years of supervisory/management experience, or the equivalent combination of education and experience
  • Significant hospital or treatment center customer engagement experience
  • Drives results through a large, layered team and across the matrixed field and HQ organization, inspiring through clear vision and role model leadership
  • Leads by example in fostering the highest level of teamwork and collaboration; exceptional coach
  • Exceptional executive level customer service; exemplary communication skills
  • Strategic and critical thinker, sound complex decision maker; ability to influence internal executive management to drive strategy
  • Long term strategic planner, balanced with the ability to drive real-time results with sense of urgency
  • Strong understanding of marketing trends and best practices to influence marketing team
  • Demonstrated understanding of the legal, regulatory, and compliance environment, ability to model expected behavior for the team and shape policies
  • Innovative mindset with an entrepreneurial spirit and courage to challenge the status quo to develop innovative and focused approaches to enable launch through data and technology
  • Full understanding of the healthcare system and experience leading/influencing hospital teams, promotion, and headquarters strategies
  • Deep understanding of health systems, hospital systems, etc. and the ability to develop and drive system level matrix planning and execution
Responsibilities
  • Delivers customer-facing team results for the Type 1 Diabetes Business Unit
  • Builds the T1D field organization, defining the strategy for the build, hiring the best team, and coaching a team of coaches in a hands-on and tailored fashion
  • Develops and fosters a high-performance culture and a highly engaged team
  • Establishes the account planning process and executes the treatment center plan for the account managers, and sets appropriate goals for the team(s); helps to shape forecasts based on market insights, tracks actual performance against expectations, modifies strategies in response, and holds the team accountable for delivery of results
  • Engages critical customers, particularly to facilitate novel cell therapy adoption and a new treatment model
  • Collaborates across functions to pivot the strategy with urgency to advance the longer-term strategy
  • Actively influences the marketing strategy, helping to shape our approach to treatment center models and referring healthcare provider education
  • Drives the team’s adoption of digital and innovative approaches to customer engagement
  • Partners exceptionally well and compliantly with field and HQ stakeholders including marketing, medical, market access, patient support, compliance, field operations, HR, and others to shape cross functional efforts as an influential leader; helps define unique ways of working across teams
  • Builds the most trustworthy team in the industry, role models and instills a culture of compliance focused on ethics and integrity in all we do
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself through its commitment to scientific innovation and strategic partnerships, allowing it to address unmet medical needs effectively. The company's goal is to improve the quality of life for patients with severe conditions by bringing transformative treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • EU approval for expanded cystic fibrosis treatment boosts market penetration in Europe.
  • Partnership with Arbor Biotechnologies opens new therapeutic areas and innovation opportunities.
  • Significant investments from firms indicate strong confidence in Vertex's growth potential.

What critics are saying

  • Increased competition in cystic fibrosis market may impact Vertex's market share.
  • Potential delays in EU clinical trials could affect new drug approval timelines.
  • Layoffs in Rhode Island suggest possible internal restructuring challenges or financial pressures.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on severe diseases with unmet medical needs, like cystic fibrosis.
  • The company invests heavily in R&D and strategic partnerships for drug development.
  • Vertex's innovative cell therapies position it at the forefront of biotechnology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

PBN
Jun 10th, 2025
Vertex Pharmaceuticals to lay off 125 R.I. employees

PROVIDENCE - Vertex Pharmaceuticals Inc. is laying off 125 people in Rhode Island, according to a WARN notice filed with the R.I. Department of Labor and Training on June 8.

Buniversity
May 1st, 2025
VERTEX upset Grayhound for spot at BLAST Showdown

VERTEX locked in a first-place finish at Fortress OCE Masters Fall 2022 Finals in Melbourne to qualify for BLAST Premier Fall Showdown.

BioSpace
Apr 14th, 2025
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Vertex researcher, Paul Negulescu Ph.D., receives the 2025 Canada Gairdner International Award for pioneering Research and discovery of medicines for Cystic Fibrosis.

Biz Owner Daily
Apr 7th, 2025
EU Approves Expanded Label for Vertex Pharmaceuticals' Cystic Fibrosis Treatment

Vertex Pharmaceuticals has received approval from the European Union to broaden the label for its cystic fibrosis treatment.

Slater Sentinel
Mar 23rd, 2025
Stevens Capital Management LP Makes New $829,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Stevens Capital Management LP makes new $829,000 investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).